15 February 2017
QUÉBEC CITY – Merck Canada is partnering with the FRQS to create « Oncopole », a new research, development and investment hub designed to accelerate, on all fronts, the fight against cancer. This innovative and structuring project is moving forward on solid footing thanks to a 15-million dollar funding commitment over three years from Merck.
Unveiled on February 15, 2017 in Québec City with several Québec government, FRQS and Merck Canada representatives in attendance, Oncopole is designed to bring all stakeholders and actors involved in the fight against cancer together around common strategic objectives, putting patients at the heart of its actions. In the past year, over 50 experts have been working together towards the implementation of the organisation whose operating budget will be entirely managed by the FRQS.